NCT00558896 · BASELINE
Baseline characteristics
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- denoms
- counts
- group Id
- BG000
- value
- 60
- group Id
- BG001
- value
- 34
- group Id
- BG002
- value
- 35
- group Id
- BG003
- value
- 35
- group Id
- BG004
- value
- 60
- group Id
- BG005
- value
- 120
- group Id
- BG006
- value
- 33
- group Id
- BG007
- value
- 377
- units
- Participants
- groups
- description
- Pomalidomide: 2 mg orally once daily, days 1-28 of 28 day cycle Dexamethasone: 40 mg on days 1, 8, 15 ad 22 of 28 day cycle
- id
- BG000
- title
- Relapsed Myeloma (<4 Prior Regimens): Low Dose
- description
- Pomalidomide: 2 mg orally once daily, days 1-28 of 28 day cycle Dexamethasone: 40 mg on days 1, 8, 15 ad 22 of 28 day cycle
- id
- BG001
- title
- Lenalidomide Refractory Myeloma: Low Dose
- description
- Pomalidomide: 2 mg orally once daily, days 1-28 of 28 day cycle Dexamethasone: 40 mg on days 1, 8, 15 ad 22 of 28 day cycle
- id
- BG002
- title
- Bortezomib/Lenalidomide Refractory/Relapsed Myeloma: Low Dose
- description
- Pomalidomide: 4 mg orally once daily, days 1-28 of 28 day cycle Dexamethasone: 40 mg on days 1, 8, 15 ad 22 of 28 day cycle
- id
- BG003
- title
- Bortezomib/Lenalidomide Relapsed/Refractory Myeloma: High Dose
- description
- Pomalidomide: 4 mg orally once daily, days 1-28 of 28 day cycle Dexamethasone: 40 mg on days 1, 8, 15 ad 22 of 28 day cycle
- id
- BG004
- title
- Relapsed Myeloma (< 4 Prior Regimens): High Dose
- description
- Pomalidomide: 4 mg orally once daily, days 1-21 of 28 day cycle Dexamethasone: 40 mg on days 1, 8, 15 ad 22 of 28 day cycle
- id
- BG005
- title
- Relapsed/Refractory Myeloma: High Dose
- description
- Pomalidomide: 2 mg orally once daily, days 1-28 of 28 day cycle Dexamethasone: 40 mg on days 1, 8, 15 ad 22 of 28 day cycle
- id
- BG006
- title
- Relapsed Amyloidosis: Low Dose
- description
- Total of all reporting groups
- id
- BG007
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- lower Limit
- 35
- upper Limit
- 88
- value
- 65.5
- group Id
- BG001
- lower Limit
- 39
- upper Limit
- 77
- value
- 61.5
- group Id
- BG002
- lower Limit
- 39
- upper Limit
- 77
- value
- 62
- group Id
- BG003
- lower Limit
- 45
- upper Limit
- 77
- value
- 61
- group Id
- BG004
- lower Limit
- 32
- upper Limit
- 82
- value
- 65.5
- group Id
- BG005
- lower Limit
- 36
- upper Limit
- 85
- value
- 65
- group Id
- BG006
- lower Limit
- 52
- upper Limit
- 82
- value
- 66
- group Id
- BG007
- lower Limit
- 32
- upper Limit
- 88
- value
- 64
- dispersion Type
- FULL_RANGE
- param Type
- MEDIAN
- title
- Age, Continuous
- unit Of Measure
- years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 24
- group Id
- BG001
- value
- 11
- group Id
- BG002
- value
- 8
- group Id
- BG003
- value
- 14
- group Id
- BG004
- value
- 20
- group Id
- BG005
- value
- 47
- group Id
- BG006
- value
- 14
- group Id
- BG007
- value
- 138
- title
- Female
- measurements
- group Id
- BG000
- value
- 36
- group Id
- BG001
- value
- 23
- group Id
- BG002
- value
- 27
- group Id
- BG003
- value
- 21
- group Id
- BG004
- value
- 40
- group Id
- BG005
- value
- 73
- group Id
- BG006
- value
- 19
- group Id
- BG007
- value
- 239
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 60
- group Id
- BG001
- value
- 34
- group Id
- BG002
- value
- 35
- group Id
- BG003
- value
- 35
- group Id
- BG004
- value
- 60
- group Id
- BG005
- value
- 120
- group Id
- BG006
- value
- 33
- group Id
- BG007
- value
- 377
- title
- United States
- param Type
- NUMBER
- title
- Region of Enrollment
- unit Of Measure
- participants
Complete source fields
- denoms
- counts
- group Id
- BG000
- value
- 60
- group Id
- BG001
- value
- 34
- group Id
- BG002
- value
- 35
- group Id
- BG003
- value
- 35
- group Id
- BG004
- value
- 60
- group Id
- BG005
- value
- 120
- group Id
- BG006
- value
- 33
- group Id
- BG007
- value
- 377
- units
- Participants
- groups
- description
- Pomalidomide: 2 mg orally once daily, days 1-28 of 28 day cycle Dexamethasone: 40 mg on days 1, 8, 15 ad 22 of 28 day cycle
- id
- BG000
- title
- Relapsed Myeloma (<4 Prior Regimens): Low Dose
- description
- Pomalidomide: 2 mg orally once daily, days 1-28 of 28 day cycle Dexamethasone: 40 mg on days 1, 8, 15 ad 22 of 28 day cycle
- id
- BG001
- title
- Lenalidomide Refractory Myeloma: Low Dose
- description
- Pomalidomide: 2 mg orally once daily, days 1-28 of 28 day cycle Dexamethasone: 40 mg on days 1, 8, 15 ad 22 of 28 day cycle
- id
- BG002
- title
- Bortezomib/Lenalidomide Refractory/Relapsed Myeloma: Low Dose
- description
- Pomalidomide: 4 mg orally once daily, days 1-28 of 28 day cycle Dexamethasone: 40 mg on days 1, 8, 15 ad 22 of 28 day cycle
- id
- BG003
- title
- Bortezomib/Lenalidomide Relapsed/Refractory Myeloma: High Dose
- description
- Pomalidomide: 4 mg orally once daily, days 1-28 of 28 day cycle Dexamethasone: 40 mg on days 1, 8, 15 ad 22 of 28 day cycle
- id
- BG004
- title
- Relapsed Myeloma (< 4 Prior Regimens): High Dose
- description
- Pomalidomide: 4 mg orally once daily, days 1-21 of 28 day cycle Dexamethasone: 40 mg on days 1, 8, 15 ad 22 of 28 day cycle
- id
- BG005
- title
- Relapsed/Refractory Myeloma: High Dose
- description
- Pomalidomide: 2 mg orally once daily, days 1-28 of 28 day cycle Dexamethasone: 40 mg on days 1, 8, 15 ad 22 of 28 day cycle
- id
- BG006
- title
- Relapsed Amyloidosis: Low Dose
- description
- Total of all reporting groups
- id
- BG007
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- lower Limit
- 35
- upper Limit
- 88
- value
- 65.5
- group Id
- BG001
- lower Limit
- 39
- upper Limit
- 77
- value
- 61.5
- group Id
- BG002
- lower Limit
- 39
- upper Limit
- 77
- value
- 62
- group Id
- BG003
- lower Limit
- 45
- upper Limit
- 77
- value
- 61
- group Id
- BG004
- lower Limit
- 32
- upper Limit
- 82
- value
- 65.5
- group Id
- BG005
- lower Limit
- 36
- upper Limit
- 85
- value
- 65
- group Id
- BG006
- lower Limit
- 52
- upper Limit
- 82
- value
- 66
- group Id
- BG007
- lower Limit
- 32
- upper Limit
- 88
- value
- 64
- dispersion Type
- FULL_RANGE
- param Type
- MEDIAN
- title
- Age, Continuous
- unit Of Measure
- years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 24
- group Id
- BG001
- value
- 11
- group Id
- BG002
- value
- 8
- group Id
- BG003
- value
- 14
- group Id
- BG004
- value
- 20
- group Id
- BG005
- value
- 47
- group Id
- BG006
- value
- 14
- group Id
- BG007
- value
- 138
- title
- Female
- measurements
- group Id
- BG000
- value
- 36
- group Id
- BG001
- value
- 23
- group Id
- BG002
- value
- 27
- group Id
- BG003
- value
- 21
- group Id
- BG004
- value
- 40
- group Id
- BG005
- value
- 73
- group Id
- BG006
- value
- 19
- group Id
- BG007
- value
- 239
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 60
- group Id
- BG001
- value
- 34
- group Id
- BG002
- value
- 35
- group Id
- BG003
- value
- 35
- group Id
- BG004
- value
- 60
- group Id
- BG005
- value
- 120
- group Id
- BG006
- value
- 33
- group Id
- BG007
- value
- 377
- title
- United States
- param Type
- NUMBER
- title
- Region of Enrollment
- unit Of Measure
- participants
Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f
Preserved source evidence · Not medical advice
Triangle